-
UroGen Pharma (NASDAQ:URGN) Given "Buy" Rating at D. Boral Capital
来源: Buzz FX / 15 1月 2025 11:46:17 America/New_York
UroGen Pharma (NASDAQ:URGN) Given "Buy" Rating at D. Boral Capital Written by MarketBeat January 15, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reaffirmed by D.
Read more...